| 1Cetuximab |
|---|
search
Applications
Cetuximab on bioZen 1.8 um SEC-3
25044
Separation Mode: Size Exclusion
Size Exclusion
SEC-3
HPLC
Biopharmaceutical
Pharmaceutical
Biopharmaceutical
Pharmaceutical
Pharmaceutical: Therapeutic Uses
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25044)
Column: |
Brand Name: bioZen |
Part No: |
Phase Name: SEC-3 |
System: Agilent Technologies Agilent Technologies 1200 Series |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.